Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 17 studies | 39% ± 10% | |
lung | 16 studies | 36% ± 14% | |
intestine | 9 studies | 29% ± 12% | |
kidney | 7 studies | 32% ± 4% | |
eye | 7 studies | 24% ± 10% | |
liver | 7 studies | 27% ± 17% | |
brain | 6 studies | 26% ± 7% | |
lymph node | 5 studies | 32% ± 16% | |
pancreas | 4 studies | 55% ± 20% | |
placenta | 4 studies | 32% ± 19% | |
bone marrow | 4 studies | 26% ± 8% | |
uterus | 4 studies | 34% ± 15% | |
breast | 4 studies | 27% ± 7% | |
adrenal gland | 3 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4451.82 | 1445 / 1445 | 100% | 113.14 | 183 / 183 |
lung | 100% | 4964.18 | 578 / 578 | 100% | 119.73 | 1155 / 1155 |
ovary | 100% | 3949.68 | 180 / 180 | 100% | 156.54 | 430 / 430 |
stomach | 100% | 3825.36 | 359 / 359 | 100% | 104.20 | 286 / 286 |
brain | 100% | 4406.15 | 2641 / 2642 | 100% | 163.34 | 705 / 705 |
breast | 100% | 5046.40 | 459 / 459 | 100% | 126.13 | 1117 / 1118 |
kidney | 100% | 5783.29 | 89 / 89 | 100% | 107.85 | 900 / 901 |
thymus | 100% | 6133.81 | 653 / 653 | 100% | 145.80 | 604 / 605 |
intestine | 100% | 4393.90 | 966 / 966 | 100% | 107.60 | 526 / 527 |
prostate | 100% | 5500.16 | 245 / 245 | 100% | 157.53 | 501 / 502 |
skin | 100% | 4792.29 | 1809 / 1809 | 100% | 128.18 | 471 / 472 |
uterus | 100% | 4469.77 | 170 / 170 | 100% | 112.20 | 458 / 459 |
liver | 100% | 3091.53 | 226 / 226 | 100% | 81.56 | 405 / 406 |
pancreas | 100% | 2414.30 | 327 / 328 | 100% | 105.20 | 178 / 178 |
bladder | 100% | 4569.71 | 21 / 21 | 99% | 124.20 | 501 / 504 |
adrenal gland | 100% | 6891.25 | 258 / 258 | 99% | 104.75 | 228 / 230 |
adipose | 100% | 5019.19 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 151.78 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 154.42 | 29 / 29 |
spleen | 100% | 6604.37 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 94.82 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 138.86 | 1 / 1 |
blood vessel | 100% | 3827.73 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 3832.22 | 859 / 861 | 0% | 0 | 0 / 0 |
muscle | 100% | 3687.68 | 801 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 6463.01 | 924 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007040 | Biological process | lysosome organization |
GO_0001558 | Biological process | regulation of cell growth |
GO_0001919 | Biological process | regulation of receptor recycling |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0031669 | Biological process | cellular response to nutrient levels |
GO_0016197 | Biological process | endosomal transport |
GO_0032418 | Biological process | lysosome localization |
GO_0060620 | Biological process | regulation of cholesterol import |
GO_0007032 | Biological process | endosome organization |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_0010874 | Biological process | regulation of cholesterol efflux |
GO_0008104 | Biological process | protein localization |
GO_1904263 | Biological process | positive regulation of TORC1 signaling |
GO_0032008 | Biological process | positive regulation of TOR signaling |
GO_0072657 | Biological process | protein localization to membrane |
GO_0150032 | Biological process | positive regulation of protein localization to lysosome |
GO_0038202 | Biological process | TORC1 signaling |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0031902 | Cellular component | late endosome membrane |
GO_0035579 | Cellular component | specific granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0005764 | Cellular component | lysosome |
GO_0035577 | Cellular component | azurophil granule membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0101003 | Cellular component | ficolin-1-rich granule membrane |
GO_0071986 | Cellular component | Ragulator complex |
GO_1990877 | Cellular component | FNIP-folliculin RagC/D GAP |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0043495 | Molecular function | protein-membrane adaptor activity |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0051020 | Molecular function | GTPase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LAMTOR1 |
Protein name | Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) Late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) (Lipid raft adaptor protein p18) (Protein associated with DRMs and endosomes) (p27Kip1-releasing factor from RhoA) (p27RF-Rho) |
Synonyms | PP7157 PDRO C11orf59 |
Description | FUNCTION: Key component of the Ragulator complex, a multiprotein complex involved in amino acid sensing and activation of mTORC1, a signaling complex promoting cell growth in response to growth factors, energy levels, and amino acids . Activated by amino acids through a mechanism involving the lysosomal V-ATPase, the Ragulator plays a dual role for the small GTPases Rag (RagA/RRAGA, RagB/RRAGB, RagC/RRAGC and/or RagD/RRAGD): it (1) acts as a guanine nucleotide exchange factor (GEF), activating the small GTPases Rag and (2) mediates recruitment of Rag GTPases to the lysosome membrane . Activated Ragulator and Rag GTPases function as a scaffold recruiting mTORC1 to lysosomes where it is in turn activated . LAMTOR1 is directly responsible for anchoring the Ragulator complex to the lysosomal membrane . LAMTOR1 wraps around the other subunits of the Ragulator complex to hold them in place and interacts with the Rag GTPases, thereby playing a key role in the recruitment of the mTORC1 complex to lysosomes . Also involved in the control of embryonic stem cells differentiation via non-canonical RagC/RRAGC and RagD/RRAGD activation: together with FLCN, it is necessary to recruit and activate RagC/RRAGC and RagD/RRAGD at the lysosomes, and to induce exit of embryonic stem cells from pluripotency via non-canonical, mTOR-independent TFE3 inactivation (By similarity). Also required for late endosomes/lysosomes biogenesis it may regulate both the recycling of receptors through endosomes and the MAPK signaling pathway through recruitment of some of its components to late endosomes . May be involved in cholesterol homeostasis regulating LDL uptake and cholesterol release from late endosomes/lysosomes . May also play a role in RHOA activation . . |
Accessions | F5H479 ENST00000544594.5 H0YFI1 Q6IAA8 ENST00000535107.5 ENST00000535872.1 ENST00000538404.1 F5GX19 ENST00000545249.5 ENST00000278671.10 F5H267 F5H3Y3 |